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Abstract
With numerous HIV service gaps in prisons and jails, there has been little research on HIV stigma 
attitudes among correctional staff. Such attitudes may undermine HIV services for inmates at risk 
of or infected with HIV. This HIV stigma attitudes survey among 218 correctional staff in 32 US 
facilities (1) provides an overview of staff’s stigma attitudes, (2) reports psychometric analyses of 
domains in Earnshaw and Chaudoir’s HIV Stigma Framework (HSF), and (3) explores differences 
in stigma attitudes among different staff types. Overall, correctional and medical staff expressed 
non stigmatizing attitudes toward people living with HIV/AIDS, but perceived that stigma and 
discrimination exist in others. Factor analyses revealed a three factor structure capturing two 
mechanisms of the HSF (prejudice, discrimination). Few factor score differences were found by 
staff type or setting. Implications for correctional HIV services and future research on HIV stigma 
attitudes are discussed.
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Introduction
The prevalence of the human immunodeficiency virus (HIV) among state prison and local 
jail inmates is substantially higher than in the general population.1 In 2010, 1.5 % of state 
prison inmates were known to have HIV or acquired immunodeficiency syndrome (AIDS), 
an estimated four times the prevalence in the general U.S. population [1, 2]. The Centers for 
Disease Control and Prevention (CDC) estimates that approximately 14 % of people living 
with HIV pass through the corrections system each year [1]. Yet, many correctional facilities 
do not adhere to CDC guidelines for HIV testing, prevention, or treatment [3, 4]. If HIV 
testing is not expanded or targeted to high-risk inmates, many infections will go unreported 
or undiagnosed [5]. Models of sexually transmitted disease transmission dynamics [6–8] 
suggest that reducing or preventing infections in core risk groups, such as inmates, can 
greatly reduce transmission in the community. Undiagnosed HIV infection, inadequate 
access to antiretroviral therapy (ART), and poor ART adherence are substantial public 
health problems in the U.S. incarcerated population, raising the importance of increasing 
testing and treatment. New U.S. guidelines suggest that all confirmed HIV-positive persons 
should be started on ART as part of a treatment as prevention (TasP) approach [9]. TasP 
strives to reduce HIV-transmission risk by having any confirmed HIV-positive persons 
receive ART and immediately attempt to establish viral suppression. Successful viral 
suppression reduces transmission risk even if the person engages in HIV risk behavior [9]. 
This is particularly applicable to correctional settings as inmates frequently transition from 
the correctional setting to the community and back, and may continue to engage in 
transmission risk behavior. Thus, successful engagement in treatment is critical to the health 
of the inmate as well as the public.
Stigma can be defined as “exposure to negative attitudes, structural and interpersonal 
experiences of discrimination or unfair treatment, and violence perpetrated against persons 
who belong to disadvantaged social groups,” [10], and stigma has been studied with regard 
to HIV/AIDS [11]. Within the correctional system, stigmatizing attitudes among both 
inmates and correctional staff may be important factors influencing whether individuals seek 
services in the HIV services continuum (prevention, testing, and treatment for those 
identified as infected with HIV). Stigma creates barriers to expanding and improving HIV 
services [12–14], and can undermine efforts to expand HIV testing, incorporate evidenced-
based HIV prevention into routine practice, encourage inmates to self-disclose their HIV 
status, and increase access and adherence to ART [12–15]. New knowledge about stigma in 
correctional institutions can help inform training and educational approaches to reduce such 
stigma and discrimination. Utilizing Earnshaw and Chaudoir’s HIV Stigma Framework 
(HSF) [12], this paper explores HIV stigma and stigma attitudes among a national sample of 
correctional staff.
1Prisons are operated by state correctional agencies and generally house inmates convicted of felony crimes sentenced to more than 
one year of incarceration. Jails are operated by county or city agencies and house inmates awaiting trial or those convicted of 
misdemeanors and sentenced to one year or less of incarceration. In this paper, the terms “correctional facility” or “corrections” are 
used generically to indicate both prisons and jails.
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HIV Services in Correctional Settings
CDC guidelines for HIV testing in correctional settings point to a need to expand and 
improve HIV testing in prisons and jails, especially opt-out testing [4]. In particular, inmates 
at high risk for HIV infection, such as those with histories of injection drug use, or those 
known to have had sex or injected drugs in prison, should be routinely offered annual opt-
out testing (where testing is done for all inmates unless the inmate specifically declines the 
test), and HIV testing prior to release (especially in facilities located in high-prevalence 
states). Although opt-out testing involves higher up-front costs, studies have shown that it is 
as cost-effective as other types of screening even when HIV prevalence is as low as 0.1 % 
(with an HIV prevalence of 1.5 % among state prison inmates, opt-out HIV testing in 
prisons and jails is likely to be highly cost effective; see [4]). In addition, improved testing 
has a direct positive public health impact in that many people reduce risk behaviors after 
being diagnosed with HIV [16].
If an inmate is known to be HIV-positive, or tests positive for HIV while incarcerated, 
appropriate ART should begin immediately when clinically appropriate and continue for the 
duration of their incarceration [17]. Directly administered antiretroviral therapy (DAART) is 
a technique for dispensing medications to inmates in which the patient obtains the 
medication from the medical staff and ingests the pills immediately under observation, and 
is feasible for incarcerated individuals [18, 19]; greater treatment initiation and adherence by 
HIV positive inmates has been found in settings that adopt DAART procedures [19, 20]. 
Another, but perhaps less effective strategy in correctional facilities is self-administered 
therapy (SAT) or keep-on-person (KOP), in which the patient obtains a weekly or monthly 
supply of the medication and self-administers the drugs on his or her own [21–23].
Establishing and maintaining appropriate privacy and confidentiality for inmates is crucial 
for establishing an institutional climate in which inmates feel comfortable seeking HIV 
testing, disclosing their serostatus, expressing their concern about their risk for HIV 
infection, or adhering to ART medication protocols. For inmates diagnosed with HIV, 
discontinuity in medications upon transition from institution to the community undermines 
public health [24]. Gaps in receiving ART increase viral load and thus transmission risk and 
reduce effectiveness of the medications, may make adherence more difficult, and ultimately 
increase public health and public safety costs [25–27]. Moreover, suboptimal adherence to 
ART (e.g., due to interruptions in HIV care—a common scenario) can lead an inmate to 
develop resistance to class-specific antiretroviral medications [28–30] thus greatly 
threatening both individual and public health. Reducing these gaps may require addressing 
institutional and community barriers to ART access that include issues related to stigma 
[15].
Prior Research on HIV Stigma in Correctional Institutions
Although a number of studies have documented HIV stigma in the general public [12, 31–
34], research is scarce on correctional staff attitudes towards inmates living with HIV. 
Perceived HIV-related stigma has been found to be a barrier to getting tested for HIV and/or 
disclosing one’s serostatus inside correctional facilities [35, 36]. People living with HIV or 
AIDS (PLWHA) who are incarcerated may fear a double stigmatization for their HIV status 
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as well as being an inmate. Additional stigma in correctional facilities as a result of sexual 
orientation or minority status may also reduce willingness to self-disclose serostatus or 
engage in HIV services.
A mid-1990s study of correctional staff attitudes towards HIV in Scottish prisons indicated 
that staff tended to perceive a greater risk of HIV infection when working in correctional 
settings and as a result had more stigmatizing feelings toward HIV-positive inmates [37]. 
Derlega and colleagues also noted evidence for stigmatizing attitudes among U.S. 
correctional staff, who rated PLWHA more negatively than those with other chronic health 
conditions [35]. Thus, there seems to be a perception of HIV-related stigma in correctional 
systems, yet little is known about the degree to which stigmatizing attitudes exist among 
correctional staff or how this may affect engagement in HIV services.
The institutional climate in self-contained and controlled settings, such as prisons or jails, 
may be shaped by negative staff attitudes or perceptions that could create an environment in 
which inmates are not comfortable learning about HIV prevention, seeking testing, or taking 
ART medications. HIV services in correctional settings are delivered in a context which is 
characterized by difficulty in implementing and sustaining effective coordinated HIV care, 
widely disparate attention paid to HIV issues across correctional facilities, and 
misinformation and stigma around HIV among staff and inmates [3, 38, 39]. Access to HIV 
services may also vary by race and gender [40]. Yet to date, there has been limited research 
on how stigma may affect these contexts and how they influence the implementation of HIV 
interventions into correctional settings. The institutional and community corrections 
climates can be indifferent or hostile toward HIV services [39, 40]. Without more research 
on the implementation barriers and facilitators for HIV services for persons under criminal 
justice supervision, HIV interventions will continue to be developed and implemented in a 
nonintegrated fashion, be less effective than they could be, and serve relatively small 
numbers of at-risk inmates [41].
Identifying and modifying potential structural sources of stigma towards inmates from 
correctional staff is necessary to help correctional facilities fulfill their constitutional 
responsibility to provide adequate medical care to inmates, and reduce the incidence of 
infectious diseases. Incarceration itself is associated with a greater likelihood of health 
problems associated with stress [42]. Unaddressed, stress associated with discrimination in 
the correctional context, may stimulate maladaptive coping behaviors (e.g., drug use) in a 
setting where risky injection practices prevail and there is a greater likelihood of adverse 
consequences of drug use such as overdose [43] and contagion with blood borne pathogens 
including HIV [44].
In addition to security staff (mainly corrections officers), inmates also interact with other 
types of staff when accessing HIV-related services. This includes nursing and other health 
care provider staff, intake counselors, social workers and case managers, drug treatment 
counselors, and educational staff. Accordingly, there is a need to further our understanding 
of the attitudes and perceptions of different types of staff who work with inmates, including 
staff in correctional settings as well as staff of community-based organizations (such as 
substance abuse treatment and HIV service providers) who also come into contact with HIV-
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positive inmates or those at risk for HIV following release from custody. Medical and 
counseling staff in correctional facilities may have lower levels of stigma and discrimination 
than security staff (due to their clinical training) and may therefore be more supportive and 
encouraging of HIV services. Less stigmatizing attitudes by medical staff can provide a 
“buffer” for inmates and reduce overall perceived stigma in the prison or jail facility. 
Variation in the levels and mechanisms of stigma among different types of staff and 
different types of setting (jail and prison) may impact their ability to function efficiently as a 
team and thus affect the delivery of services in the HIV continuum. However, we are not 
aware of any prior research that has compared HIV stigma attitudes of correctional staff and 
medical staff inside prisons or jails.
A Framework for Conceptualizing HIV Related Stigma
Although prior research on perceived HIV stigma and discrimination among corrections 
staff is lacking, the HSF proposed by Earnshaw and Chaudoir [11] may be adaptable for the 
correctional setting. The HSF differentiates between the mechanisms and related outcomes 
of stigma for PLWHA and those who are uninfected, and suggests that the mechanisms that 
produce stigma as well the outcomes produced by it differ between those two groups. 
Earnshaw and Chaudoir conceptualize HIV stigma as an indicator of social devaluation that 
is either present or absent in individuals, functioning through three mechanisms: stereotypes, 
prejudice, and discrimination [12]. Stereotypes refer to mistaken beliefs about the disease or 
infected persons which are then applied to individuals. They involve thought processes, such 
as beliefs about how the disease is contracted, which feed beliefs about the type of persons 
who are infected. Prejudice refers to negative emotional reactions toward infected persons, 
including anger, disgust, or projections of shamefulness. Discrimination is the “behavioral 
expression of prejudice,” [12, p. 1162] that manifests in specific acts to socially distance 
members of the stigmatized group from oneself or the uninfected group. Earnshaw and 
Chaudoir posit that while these mechanisms are often correlated, they represent separate 
elements of stigma with different functional attributes (cognition, emotion, and behavior). 
Individually or operating together, they represent the means through which HIV-related 
stigma among the uninfected may increase social distancing from PLWHA, reduce 
willingness to be tested for HIV, or increase support for policies that adversely affect those 
who are infected or at risk [11]. A recent study found that enacted stigma towards HIV-
positive individuals had a greater impact on their health outcomes when compared to 
perceived or internalized stigma, substantiating the need for differentiating and identifying 
the mechanisms through which stigma manifests itself [45].
Although there has been no published research to date testing the HSF on staff who are in 
contact with PLWHA or at high risk, there is ample research testing the impact of the 
components of the framework on persons at risk for or infected with HIV. A meta-analysis 
found that perceived discrimination has a significant positive association with both mental 
and physical illness, perhaps due to increased stress [46]. More generally, the Institute of 
Medicine has identified stereotyping and discrimination as contributing factors to the health 
disparities encountered by racial and ethnic minorities in the United States [47], who also 
comprise a disproportionate segment of the inmate population [1, 48, 49].
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Stigmatizing or discriminatory attitudes toward HIV among correctional staff (whether 
expressed overtly or perceived so by inmates), could [1] lead to an institutional climate that 
encourages or ignores such attitudes, [2] increase inmate reluctance to engage in prevention, 
get regular HIV tests or disclose their serostatus, and [3] present barriers to initiation and 
adherence to ART due to confidentiality concerns, a fear of stigma, and lack of information 
[15, 36]. Before new policies and procedures or training efforts are implemented to increase 
inmates’ use of HIV services, it is important to determine the extent to which stigma 
attitudes and perceptions exist among staff working in these settings across the domains that 
comprise the construct. The first step towards this goal is being able to accurately measure 
various dimensions of stigma and discrimination among staff in correctional settings.
Goals of the Study
As part of the National Institute on Drug Abuse’s Criminal Justice Drug Abuse Treatment 
Studies (CJDATS) cooperative agreement comprised of nine research centers (RCs), the 
authors were involved in the HIV Services and Treatment Implementation in Corrections 
(HIV-STIC) study, which experimentally tested a process improvement model to improve 
delivery of HIV services in correctional facilities. The baseline data collection allowed us to 
study HIV stigma in questionnaires that were administered to the corrections staff. Informed 
by the HSF proposed by Earnshaw and Chaudoir [12], this paper explores the perceptions 
and attitudes around HIV stigma in our national sample of staff working in a sample of 
prisons and jails in 8 states and Puerto Rico, conducted as part of the HIV-STIC project 
[50].
The goals of the present study are: [1] to provide a general overview of staff’s level of 
stigma, [2] to report preliminary psychometric analyses of two of the HSF mechanism scales 
(prejudice and discrimination) adapted for correctional and related staff, [3] to explore 
differences in level and mechanisms of stigma between state prison and local jail staff, and 
[4] to explore differences between medical and treatment staff and correctional staff. We 
sought to determine the extent to which stigma attitudes differed among staff in these 
different settings and roles.
Methods
Study Sites and Sample
Data were collected as part of our larger multisite HIV-STIC study testing the impact of a 
structured organizational change intervention (utilizing a local change team with external 
coaching) for achieving improvements in HIV services for prison and jail inmates [50]. 
Under the CJDATS cooperative agreement, nine RCs implemented a multisite cluster 
randomized trial in 24 prison and 8 jail facilities located in Arizona, Colorado, Connecticut, 
Delaware, Illinois, Kentucky, Pennsylvania, Puerto Rico, and Washington State. We 
randomized matched pairs of facilities into control and experimental sites following baseline 
training on best practices in HIV services in correctional settings. All sites were directed by 
a senior correctional official to work on improving HIV services in one area of the HIV 
services continuum: testing, prevention, or linkage to HIV medical care following release. 
Experimental sites implemented structured local change teams guided by external coaches 
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utilizing a modified version of the NIATx process improvement strategy [51]. Participating 
agencies include prisons and/or jails as well as the community agencies that provided HIV 
services to inmates while incarcerated or after release.
Because we were interested in assessing stigma attitudes among correctional leadership and 
staff that were involved in HIV service delivery, we used a purposive sample comprising all 
administrators and staff responsible for the oversight and delivery of HIV services at each of 
the research sites. Staff included correctional and/or community medical staff, correctional 
staff responsible for HIV infected inmates, case managers, and prevention educators, as well 
as facility administrators and corrections officers. These staff participated in HIV services 
training and other aspects of the HIV-STIC project. Additional correctional staff (e.g., 
security staff and administrators with responsibility for HIV medical services) were 
recruited to participate in the survey. Surveys (including items related to perceived value of 
HIV services and attitudes toward evidence-based practices, as well as the stigma items 
detailed below) were obtained from each of the individuals who provided informed consent. 
A total of 246 baseline surveys were distributed, with 223 completed surveys returned, a 
90.7 % response rate. Five surveys were excluded from analyses because of incomplete data 
on the stigma items. Additional details on the HIV-STIC study design and measures are 
found in our recent article [50].
After obtaining IRB-approved informed consent, the self-administered baseline survey was 
administered between June 2011 and September 2012, prior to the randomization of research 
sites to either the experimental or control arm, to prevent introducing bias related to pre-
exposure or differential exposure of staff to organizational change efforts around HIV 
services. Completed survey forms contained no identifying information and were placed in 
sealed envelopes to be collected by research staff at each RC. After preliminary quality 
assurance checks at each RC, the baseline survey data were sent to the CJDATS 
coordinating center for aggregation into a single file for additional data quality checks.
The respondents held a number of different staff positions. Among the 218 respondents 
providing information, 16 % were correctional administrators, 4 % were correctional 
security staff (i.e., corrections officers), 42 % medical staff (including 35 % correctional and 
7 % community staff), 11 % substance abuse treatment counseling staff, 15 % worked for 
community-based HIV service providers, and 12 % held a variety of other positions. 
Overall, 66 % of the respondents were correctional system staff. More than two-thirds (68.4 
%) were female, and the mean respondent age was 48.3. More than half were White (58.6 
%), 23.1 % African American, and 18.2 % other or mixed races. About one-fifth (20.8 %) 
self-identified as Hispanic.
Development and Description of the HIV/AIDS Stigma Measure
One hypothesis of the overall HIV-STIC study was that the experimental intervention would 
reduce staff perceptions of stigma against those with HIV or at risk for HIV [50]. An 
extensive literature search found several potential stigma measures, but none directly 
applicable to staff working in correctional facilities. The instrument created by Zelaya and 
colleagues [34] for an exploratory community-based HIV/STD prevention study in Chennai, 
India was selected and modified for use with correctional and community staff in the U.S. 
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The original Zelaya et al. [34] stigma scale included 24 items, many of which were selected 
from previously developed scales [e.g., 52, 53] in four conceptual domains: [1] fear of 
transmission; [2] association with shame, blame and judgment; [3] personal support of 
discriminatory actions or policies, and [4] perceived community support for discriminatory 
actions or policies. For the present study, modifications included shortening the original 
scale and rewording items to enhance their relevance to correctional staff. All items related 
to the original domain of fear of transmission as well as three of the original items from the 
shame, blame, and judgment domain were dropped from the HIV-STIC measure for lack of 
relevance to the goals of our study. Eight of the remaining original items were revised by 
omitting “in this community” because correctional facilities are not communities in the same 
sense used in the original Zelaya et al. [34] measure. The resulting scale included items 
capturing two of the three mechanisms that comprise the HSF (prejudice and 
discrimination). Because the original survey [34] did not include a domain for stereotypes, 
the modified survey did not include a stereotype domain. The analysis thus focuses on 
stigma as represented by prejudice and discrimination. The wording of the 7 remaining 
original items was not changed. The 15 items in the final modified scale are shown in Table 
1.
Analytic Plan
The analysis proceeded in three steps. First, descriptive statistics were calculated and 
distributional properties checked for each of the 15 items in the stigma scale. The second 
step included conducting an exploratory factor analysis (EFA) of the 15 items and saving the 
factor scores for further analysis. EFA was conducted rather than a confirmatory factor 
analysis (CFA) for several reasons. First, as indicated above we used a subset of the HIV/
AIDS stigma items from the Zelaya et al. scale [34] that was originally developed for use 
with community respondents in India, so modifications needed to be made to a number of 
items to enhance their relevance to the correctional and community staff that participated in 
the HIV-STIC study. Second, the study by Zelaya et al. [34] was, itself, an exploratory 
study. Finally, the stigma measure was modified because the current study was conducted in 
the United States rather than in India. Accordingly, CFA would be inappropriate for the 
present study.
Each respondent rated his/her level of agreement with each item on a 5-point Likert scale. A 
weighted least squares (WLSMV) estimation was employed because it is a robust estimator 
when used with highly skewed categorical data, as was observed in the current study. 
Exploratory structural equation modeling [ESEM; 54] was used for the exploratory factor 
analyses. ESEM is integrated with EFA measurement parts, allowing access to other 
parameters, such as correlated residuals, regressions on covariates, regressions between 
factors of different EFA sets, and mean structures [54].
Geomin [55] was used to perform an oblique rotation of the initial factor structure. It is a 
preferred rotational procedure when items are expected to load on more than one factor [56]. 
Adapted from a solution to the row complexity problem suggested by Thurstone [57, 58], 
Yates’ Geomin [55] replaced “the sum of within row products of squared reference structure 
elements by a sum of within row geometric means of squared pattern coefficients” [59, p. 
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120]. This rotation was used to estimate a series of solutions ranging from 1 to 5 factors 
using Mplus Version 7.0 [56]; see also [54]. Preliminary analyses indicated that item 8, 
“People who have HIV/AIDS should be treated the same as everyone else,” was very highly 
correlated with items 7 (r = 0.824) and 9 (r = 0.812), as well as items 5 (r = 0.722) and 6 (r = 
0.753), raising multicollinearity concerns. Hence, it was omitted from further analysis, 
reducing the item pool to 14 statements (results available from senior author upon request).
The final analytical step included subgroup comparisons on mean factor scores by setting 
(jail vs. prison facilities) and staff type (corrections staff vs. non-corrections staff; 
correctional treatment vs. community treatment staff, and corrections staff vs. medical staff) 
to determine whether the stigma attitudes differed by type of setting and staff.
Results
Descriptive Statistics for HIV/AIDS Stigma Items
In general, respondents expressed nondiscriminatory attitudes about PLWHA (items 1–9) as 
displayed in Table 1. For example, the vast majority of respondents indicated that persons 
with HIV/AIDS deserved to receive medical care, regardless of how they contracted the 
disease (item 1) and disagreed with the statement that people who associate with a person 
having HIV/AIDS will be influenced to engage in immoral or illicit activities (item 2). Most 
respondents (88 %) agreed with the statement that persons with HIV/AIDS should be treated 
the same by health care professionals as people with other illnesses (item 4), and with the 
statement that a teacher with HIV, who is not sick, should be allowed to continue teaching in 
school (item 9).
On the other hand, respondents perceived some stigma in society with regard to PLWHA 
(items 10–15). A majority agreed that persons with HIV/AIDS faced neglect, rejection, or 
abuse/teasing by others (items 10, 13, 14). About half of respondents indicated that persons 
with HIV/AIDS may face ejection from their homes by their families (item 12) or 
abandonment by their spouse or partner (item 15).
Exploratory Factor Analysis
A series of exploratory solutions, ranging from 1 to 5 factors, were computed and 
comparisons made between solutions in terms of how well each model fit the data. As 
shown in Table 2, the best solution was a five factor model which had a near perfect fit to 
the data—as reflected across multiple fit measures, including a non-significant Chi square, a 
RMSEA near 0, and CFI and TLI values of 1.
Based on item loadings (Table 3), three clear factor patterns emerged, as did two other less 
interpretable factors. The first distinct factor included 8 items, such as, “only those who 
were infected with HIV by medical needles or blood in hospitals deserve to receive 
treatment and care” and “people living with HIV/AIDS should be isolated from other 
people.” This first factor included elements from domains 2 and 3 (i.e., association with 
shame, blame, and judgment; personal support of discriminatory actions and policies, 
respectively) originally reported by Zelaya et al. [34]. Interpreted within the HSF [12], this 
factor mainly includes elements of prejudice (negative emotions and feelings towards those 
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with HIV/AIDS) with one item (#7) related to discrimination (endorsement of actions that 
socially distance one from the individual with HIV/AIDS). Factor 1 was the biggest factor, 
in that more items were significantly loaded on it, indicating it was a more general factor in 
the data. The remaining, “smaller factors” (i.e., with fewer significant item loadings), were 
more content domain specific (e.g., factor 2 referring to neglect and rejection/ejection). The 
second factor included 3 items, such as, “people living with HIV/AIDS face neglect from 
family” all of which were included in Zelaya and colleagues’ [34] fourth domain (perceived 
community support of discriminatory actions and policies); interpretation of this factor 
within the HSF suggests this factor reflects discrimination. Like the 2nd factor, the 3rd factor 
was composed of items from the fourth domain of Zelaya et al. [34], and also appears to be 
tapping the discrimination dimension described by Earnshaw and Chaudoir [12]. The scores 
for the second and third factors were highly correlated (r = 0.57, p < 0.001; Fig. 1), 
suggesting that they are both capturing the discrimination mechanism, but differ in terms of 
the extent to which the discriminatory actions are overt. For example, factor 3 includes items 
more externally visible like verbal abuse and teasing, rejection by peers, and abandonment 
by spouse or partner. As noted above, two less clear factors were also observed in our EFA. 
The fourth factor was comprised of three items which also had strong cross loadings on 
other factors, and a fifth factor had only one item. In order to improve interpretability due to 
overlap with the other factors, factor 4 was dropped from further consideration. Because 
Nunnally [60] suggests that factors should have at least 3–4 items, factor 5 also was dropped 
from further consideration.
The 32 study sites were nested within nine RCs; thus we conducted a two-level analysis in 
order to determine whether the HIV/AIDS stigma factor scores were significantly different 
among the RCs at level 2 (results not shown). Results indicated close to zero intraclass 
correlations for the factor scores (highest intraclass correlation = 0.048). Thus, there was no 
need to conduct further two-level analyses on factor scores.
Subgroup Comparisons
Scores were compared on the three main scale factors for different types of staff and type of 
correctional setting. Contrary to our hypothesis, we found few differences in factor scores as 
a function of staff type or setting (Table 4) aside from factor 1, where corrections treatment 
staff had significantly higher scores than community treatment staff, indicating higher levels 
of perceived stigma [F(1, 156) = 9.46, p < 0.01]. Confirming the consistency of attitudes 
across staff subgroups, comparisons of individual scale items revealed very few significant 
differences. For item 3 (“People who have HIV/AIDS should be given treatment and care 
only if they stop participating in immoral or illegal activities”), community treatment staff 
were more likely to disagree or strongly disagree than corrections treatment staff (98 vs. 82 
%, p < 0.05). For item 10 (“People living with HIV/AIDS face neglect from their family”), 
medical staff were more likely to agree or strongly agree than corrections staff (54 vs. 39 %, 
p < 0.05).
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Discussion
To examine HIV/AIDS stigma attitudes among correctional leadership and staff involved in 
HIV services, we adapted a previous stigma scale and conducted a survey of stigma attitudes 
in 32 prison and jail facilities in 8 states and Puerto Rico, as part of a larger national 
multisite study. The purpose of this paper was to explore staff’s level of stigma and 
discrimination, to report preliminary psychometric analyses of a stigma attitudes scale 
adapted for correctional and related staff, and to examine differences by type of staff and 
correctional facility.
Although community and medical staff responded in a more empathetic manner on certain 
items compared with other types of staff, for the most part staff expressed nondiscriminatory 
attitudes regarding PLWHA and indicated that they should be treated in a supportive 
manner. However, staff perceived that stigmatization and discrimination continues to exist 
across US society as a whole. Although this was not a random or representative sample of 
staff who work with correctional populations, the finding suggests a positive trend among 
diverse staff across the US and Puerto Rico with regard to the potential for reduced stigma/
discrimination for PLWHA in correctional settings.
The factor analyses revealed that a three-factor structure provided the best solution for the 
adapted scale. Our 3-factor scale differed somewhat from the original scale [34] in terms of 
factor structure, but successfully captured the same key elements and tapped into two of the 
domains that comprise the HSF (i.e., prejudice and discrimination; [12]). Thus, our adapted 
scale may be a useful tool in future research to examine the influence of HIV-related stigma 
in the correctional system as HIV services are expanded and improved.
The relatively low level of expressed stigma across all staff subgroups is encouraging, and 
the lack of variation across study sites also indicates that stigma is rather low in areas that 
encompass most regions of the United States. It should be noted, however, that some stigma 
attitudes persist among correctional staff. Six percent of respondents either agreed (1 %), 
strongly agreed (2 %) or had no opinion (3 %) concerning the statement that only those who 
were infected by medical needles or blood in a hospital deserved care and treatment. 
Although six percent is a low endorsement rate, that particular statement is heavily 
judgment-laden and indicates an attitude that is inconsistent with being supportive of a high-
risk incarcerated population. The percentages in the response category “no opinion” ranged 
from 3 to 53 %. No opinion responses were highest on those items that focused on how 
other persons treated PLWHA. They were the lowest on the direct personal opinion items. 
The items measuring how others treated PLWHA also has substantially more negative 
responses than the personal opinion items. These results suggest that correctional staff either 
perceive or have observed that others hold stigmatizing attitudes toward PLWHA, or are 
unsure about the level of stigma among others. This suggests a need for further research on 
HIV stigma among broader samples of correctional and health services staff (especially 
security staff), as well as inmates.
The impact of even low levels of stigma can have pronounced effects in prison settings. 
Prison environments are by their nature compressed and insular, such that attitudes or 
Belenko et al. Page 11
AIDS Behav. Author manuscript; available in PMC 2017 January 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
behaviors by small numbers of staff are noticed and discussed, and can affect inmates’ 
perceptions and behaviors. There is a difference between outwardly stigmatizing people 
through words and actions and allowing minor slights or negative attitudes to permeate, but 
in institutional environments, the latter can be just as detrimental as the former in terms of 
an inmate’s willingness to get an HIV test, participate openly in prevention programming or 
disclose a known positive serostatus and begin ART. Many of the study participants were 
involved in HIV care, and thus likely to be more knowledgeable about the realities of HIV 
and PLWHA, and be aware of which inmates were HIV-positive, than most front line 
security staff. But it is the front line security staff that control movement on the cell blocks, 
including escorting inmates from their cells to obtain medical care, including HIV testing 
and care. However, our sample had too few security staff respondents to provide valid 
measures of their stigma attitudes.
Some relatively straightforward changes in institutional policies and procedures may reduce 
the negative impact of stigmatizing or discriminatory attitudes, whether perceived or overt. 
For example, the process for opt-in testing can require inmates to file a sick call slip, attend 
the sick call line with other inmates, get the HIV test and, in cases where rapid tests are not 
used, go through the sick call line again to receive the results. At each stage of this process, 
inmates may be asked by other inmates or staff why they are seeing to the doctor. To the 
extent that inmates perceive stigma or discrimination from others, this may deter them from 
requesting HIV tests under an opt-in protocol. Implementing op-out HIV testing (ideally 
using rapid testing procedures) as part of routine medical exams would remove the burden 
of requesting a test from the inmate and increase the number of inmates willing to be tested 
[4].
Reducing the impact of stigma on obtaining and adhering to HIV medications is potentially 
more difficult than reducing testing barriers. An inmate who goes to sick call or the pill line 
daily (i.e., the DAART technique) is likely to be asked what is wrong by staff or other 
inmates [36]. Likewise, inmates who are allowed to keep their medications with them (i.e., 
the SAT/KOP technique) may also seek ways to maintain confidentiality, particularly when 
they share a cell with another inmate [35]. Future empirical studies of the feasibility of 
differing approaches to providing ART would be highly beneficial. A final issue suggested 
by our findings concerns the “otherness” of stigma. As noted above, our respondents rated 
their own attitudes and opinions concerning PLWHA as reflecting low stigma or 
discrimination, but rated the way other people treat PLWHA in a more negative fashion. 
Although not addressed in the current study, it is possible that inmates feel much the same 
way (“I don’t stigmatize, but others do”). The extent to which inmates perceive that 
correctional staff (or other inmates) stigmatizes PLWHA may present barriers to obtaining 
HIV tests, ART, or participating in prevention activities, regardless of the actual attitudes 
among staff and inmates. Positive messaging and proper education and prevention services 
provided to both inmates and staff may lessen the actual or perceived burden inmates 
encounter when accessing HIV services within the closed environments of prisons and jails. 
Programs modeled to accomplish this should be tested and could potentially have a positive 
impact on the number of infected inmates identified and receiving proper treatment while 
incarcerated, thereby improving overall public health.
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Limitations and Conclusion
Several study limitations should be noted. First, survey respondents were not randomly 
selected from among all staff at the various agencies represented in this project, and thus the 
likelihood of selection bias must be noted. Most respondents were selected for their 
involvement in the HIV-STIC project or their role in delivery of HIV services at the study 
sites. Other staff members were recruited to represent the views of key staff types such as 
correctional administrators and security staff. Therefore, our findings are likely to not be 
generalizable to all staff at the study sites, nor to U.S. correctional staff in general. However, 
the purpose of our study was not to assess stigma attitudes among all correctional staff, and 
our sample was representative of staff likely to come into regular contact with inmates with 
HIV or receiving HIV services. Most correctional staff does not have such contact, and HIV 
services are not a routine part of correctional staff’s daily work. Accordingly, the value of 
assessing stigma among all staff is less crucial. It is more important to assess stigma among 
staff overseeing the facilities, and providing HIV testing, prevention, and treatment services. 
In addition, the high response rate is a strength of the study. Second, the study sites across 
nine CJDATS RCs are not necessarily representative of other jail or prison facilities in the 
U.S. Nonetheless, the respondents were from geographically dispersed regions of the U.S., 
and were generally familiar and involved with delivery of HIV services, so their attitudes 
and perceptions are important to document, and are likely to influence the attitudes of other 
staff at the facilities. Third, the sample included only a small percentage of correctional 
security staff, so the findings do not necessarily represent the attitudes of corrections officers 
and other security personnel. Although they do not routinely provide HIV services to 
inmates, their attitudes toward PLWHA, and the responsibilities they have for moving 
inmates to and from health and other services, may affect inmates’ willingness to engage in 
HIV services or disclose their serostatus. Future research assessing larger samples of front-
line security staff would be valuable in order to determine whether our results are 
generalizable to a broader sample of correction officers, and whether higher levels of stigma 
and discrimination attitudes exist among those staff.
Fourth, in constructing our stigma scale we drew on prior validated scales, and excluded 
items related to fear of HIV transmission. This domain might affect correctional staff 
attitudes and behavior toward HIV-positive inmates and is of potential importance in 
expanding knowledge of the factors affecting staff attitudes toward HIV and HIV stigma in 
prisons and jails, and should be included in future studies.
Finally, it is possible that social desirability influenced the staff responses to questions to the 
stigma survey items. Although the surveys were anonymous, the number of staff surveyed at 
some sites was relatively small which might raise concerns among staff about 
confidentiality. However, the fact that the largest percentage of “no opinion” responses were 
for items that focused on how others treated PLWHA, and not on the direct personal opinion 
items, may suggest that respondents were not responding in a socially desirable way. 
Nonetheless, the survey did not include any tests for social desirability, and this possibility 
cannot be ruled out.
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The current study findings supported two of the three domains that comprise stigma in the 
HSF. The addition of items capturing stereotypes would have made for a more robust 
analysis, and future research should endeavor to include all three mechanisms. Still, given 
the lack of empirical data on HIV stigma attitudes among correctional and medical services 
staff, our findings contribute to knowledge about the current perceptions in this area, and 
demonstrate that two of the three HSF mechanisms can be effectively measured in 
correctional settings.
Although we found a low level of expressed stigma and discriminatory attitudes among 
different types of correctional staff and community service providers, the perceptions that 
there are stigmatizing attitudes among others suggests that the correctional environment may 
still present barriers to accessing HIV services that in part reflect actual or perceived stigma 
toward PLWHA, and may explain the numerous gaps in HIV services that exist in 
correctional settings [3]. Additional validation and refinement of the stigma scale with 
diverse samples of correctional, medical, and HIV service provider staff, as well as inmates, 
would increase knowledge about HIV stigma in correctional settings.
More broadly, adoption of best practices in HIV care in U.S. correction facilities will require 
structural as well as cultural changes not limited to deconstructing stigmatizing attitudes 
towards PLWHA. Correctional health services are charged with providing care to a 
population group with significant health and social disparities [61] that place growing 
demands on services on already constrained budgets [62]. Provisions in the Affordable Care 
Act to address the gap in Medicaid coverage during incarceration are limited to enabling 
Medicaid coverage for inpatient medical care; suspending rather than terminating Medicaid 
benefits upon incarceration, and facilitating Medicaid enrollment during the re-entry process 
may expedite transition to community care and improve ART adherence [63]. Other 
important challenges to providing effective client-centered HIV health services in prisons 
include low staff-to-inmate ratios, tensions between security and health staff [64], 
insufficient staff education and training in HIV services delivery [65], and frequent transfers 
within the prison system that can interrupt care. These significant barriers notwithstanding, 
our finding that stigmatizing attitudes towards PLWHA were not prevalent among the staff 
involved in inmate HIV services should encourage interventions aimed at prison health staff 
to encourage their involvement in reducing structural and cultural factors that hinder 
provision of an effective continuum of HIV care for inmates.
With broader attention to the levels and types of stigma attitudes, new training, policies, and 
procedures can be developed and tested with the ultimate goal of increasing inmate access to 
HIV services, increasing the number of infected inmates identified, and improving initiation 
of and adherence to ART medications both within correctional facilities and following 
release to the community.
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Fig. 1. 
Final analytic solution showing measurement model with the best fit to the data. Factor 
loadings shown were ≥0.30. Factors 4 and 5 were omitted from diagram (see explanation in 
Results)
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